Seasonal allergic rhinitis: Limited effectiveness of treatments

Prescrire International

Volumn 17, Issue 93, 2008, Pages 28-32

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALLERGEN; ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CETIRIZINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DESLORATADINE; EBASTINE; EYE DROPS; FEXOFENADINE; GRASS POLLEN EXTRACT; HOMEOPATHIC AGENT; IMMUNOGLOBULIN E; IPRATROPIUM BROMIDE; LEVOCETIRIZINE; LORATADINE; MIZOLASTINE; MONTELUKAST; PLACEBO; PREDNISONE; PRESERVATIVE; PSEUDOEPHEDRINE; STEROID; TRIAMCINOLONE; VASOCONSTRICTOR AGENT;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; ATROPHY; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CATARACT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONJUNCTIVITIS; DESENSITIZATION; DROWSINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY NOSE; EPISTAXIS; EYE DISEASE; FATIGUE; FOLLOW UP; GASTROINTESTINAL DISEASE; GRASS POLLEN; HAY FEVER; HEADACHE; HUMAN; HYPOTENSION; IMMUNOMODULATION; IMMUNOTHERAPY; INJECTION SITE EDEMA; INJECTION SITE IRRITATION; INTRAOCULAR HYPERTENSION; LOW DRUG DOSE; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; NOSE DISEASE; NOSE INFECTION; NOSE IRRITATION; NOSE OBSTRUCTION; NOSE SEPTUM PERFORATION; OPEN ANGLE GLAUCOMA; PHARYNGITIS; PRURITUS; PSYCHOPATHY; RADIOALLERGOSORBENT TEST; RAGWEED POLLEN; REVIEW; RHINITIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SEDATION; SIDE EFFECT; SKIN TEST; SNEEZING; SYMPTOMATOLOGY; SYSTEMIC DISEASE; TASTE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URTICARIA;

ACETATES; ADRENAL CORTEX HORMONES; ADULT; ALLERGENS; ASTHMA; BECLOMETHASONE; CHILD; COST-BENEFIT ANALYSIS; CROMOLYN SODIUM; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HISTAMINE H1 ANTAGONISTS; HOMEOPATHY; HUMANS; IPRATROPIUM; MALE; POLLEN; PREGNANCY; QUINOLINES; RHINITIS, ALLERGIC, SEASONAL; STEROIDS; VASOCONSTRICTOR AGENTS;

EID: 38849202463     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Parikh A and Scadding GK "Seasonal allergic rhinitis" BMJ 1997; 314: 1392-1395.
2. Dykewikz MS et al. "Diagnosis and management of rhinitis: complete guidelines of the joint task force on practice parameters in allergy, asthma, and immunology" Ann Allergy Asthma Immunol 1998; 81: 478-518.
3. "International conference on allergic rhinitis in childhood" Allergy 1999; 54 (suppl. 55): 7-34.
4. Plaut M and Valentine MD "Allergic rhinitis" N Engl J Med 2005; 353: 1934-1944.
5. Laine C et al. "In the clinic. Allergic rhinitis" Ann Intern Med 2007; 146 (7 suppl. ITC4): 1-16.
6. Bousquet J et al. "Allergic rhinitis and its impact on asthma" J Allergy Clin Immunol 200l; 108 (suppl. 5): 153-161, 167-170, 201-205 and 208-215.
7. Long A et al. "Management of allergic and nonallergic rhinitis" Evidence report/Technology assessment Number 54, Agency for Healthcare Research and Quality, May 2002: 198 pages.
8. "Allergic rhinitis" Prodigy knowledge guidance July 2006: 72 pages.
9. Bousquet J et al. "ARIA (Allergic rhinitis and its impact on asthma) classification of allergic rhinitis severity in clinical practice in France" Int Arch Allergy Immunol 2007; 143: 163-169.
10. Gendo K and Larson EB "Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis" Ann Intern Med 2004; 140: 278-289.
11. Prescrire Rédaction "béclométasone nasale hors prescription-Humexorhume des foins. Une alternative en cas de symptômes réellement gênants" Rev Prescrire 2006; 26 (272): 331.
12. Meltzer EO et al. "Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study" Clin Ther 2002; 24 (6): 942-952.
13. "Sodium cromoglicate". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 7 June 2007: 9 pages.
14. o 4%" Rev Prescrire 1995; 15 (156): 736-737.
15. Prescrire Rédaction "Collyres à visée antiallergique: une réévaluation en douceur" Rev Prescrire 2007; 27 (281): 182.
16. "Benzalkonium chloride". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 20 June 2007: 2 pages.
17. o. 8e corticoïde par voie nasale, sans progrès" Rev Prescrire 2002; 22 (224): 7-10.
18. Weiner JM et al. "Intranasal corticosteroids versus oral HI receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials" BMJ 1998; 317: 1624-1629.
19. Yáñez A and Rodrigo GJ "Intranasal corticosteroids versus topical HI receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis" Ann Allergy Asthma Immunol 2002; 89: 479-484.
20. re partie. Un corticoïde inhalé, principal médicament de l'asthme chronique" Rev Prescrire 2007; 27 (284): 436-441.
21. "Adverse effects of antihistamines. Sedation". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 7 June 2007: 2 pages.
22. o. Ne pas banaliser un antihistaminique HI, même peu sédatif" Rev Prescrire 2004; 24 (253): 574-575.
23. Prescrire Editorial Staff "Fexofenadine" Prescrire Int 1999; 8 (39): 11-13.
24. o. Un antihistaminique HI de plus" Rev Prescrire 1999; 19 (201): 811-814.
25. Prescrire Editorial Staff "Desloratadine" Prescrire Int 2002; 11 (61): 145.
26. - Prescrire Editorial Staff "Ebastine" Prescrire Int 2003; 12 (63): 16.
27. Prescrire Editorial Staff "Levocetirizine" Prescrire Int 2003; 12 (67): 171-172.
28. Prescrire Editorial Staff "Azelastine 0.1% nasal spray" Prescrire Int 1995; 4 (16): 42-43.
29. o" Rev Prescrire 1981; 1 (8): 28-29.
30. Linde K et al. "Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials" Lancet 1997; 350: 834-843 + 351: 220.
31. Aabel S "No beneficial effect of isopathic prophylactic treatment for birch pollen allergy during a low-pollen season: a double-blind, placebo-controlled clinical trial of homeopathic Betula 30c" Br Homeopath J 2000; 89 (4): 169-173.
32. Taylor MA et al. "Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series" BMJ 2000; 321: 471-476 + 322: 282.
33. Kim LS et al. "Treatment of seasonal allergic rhinitis using homeopathic preparation of common allergens in the southwest region of the US: a randomized, controlled clinical trial" Ann Pharmacother 2005; 39 (4): 617-624.
34. o. Metoo: un 6′ collyre antihistaminique, sans plus" Rev Prescrire 2005; 25 (257): 8.
35. Prescrire Editorial Staff "Vasoconstrictors: neurological and cardiovascular adverse effects" Prescrire Iint 2003; 12 (63): 21.
36. Prescrire Editorial Staff "16-1-2 Patients sous vasoconstricteur décongestionnant" Rev Prescrire 2007; 27 (290 suppl. Interactions médicamenteuses).
37. Prescrire Editorial Staff "Montelukast" Prescrire Int 1999; 8 (43): 131-134.
38. Di Lorenzo G et al. "Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in monotherapy, fluticasone plus cetirizine. fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis" Clin Exp Allergy 2004; 34: 259-267.
39. Wilson AM et al. "Leucotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis" Am J Med 2004; 116: 338-344.
40. Rodrigo GJ and Yañez MD "The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials" Ann Allergy Asthma Immunol 2006; 96: 779-786.
41. "Montelukast sodium". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 7 June 2007: 5 pages.
42. Bousquet J et al. "Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper" J Allergy Clin Immunol 1998: 102: 558-562.
43. Calderon MA et al. "Allergen injection immunotherapy for seasonal allergic rhinitis" (Cochrane review) (last update: 2006). In: "The Cochrane library" John Wiley and Sons, Chichester 2007; issue 1: 86 pages.
44. Durham SR et al. "Long-term clinical efficacy of grass-pollen immunotherapy" N Engl J Med 1999; 341: 468-475.
45. Frew AJ et al. "Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis" J Allergy Clin Immunol 2006; 117: 319-325.
46. "Allergen products". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 7 June 2007: 6 pages.
47. Stewart GE and Lockey RF "Systemic reactions from allergen immunotherapy" J Allergy Clin Immunol 1992; 90: 567-578.
48. Prescrire Editorial Staff "Risk of desensitisation" Prescrire Int 1996; 5 (21): 23.
49. Wilson DR et al. "Sublingual immunotherapy for allergic rhinitis" (Cochrane review) (last update: 2003). In: "The Cochrane Library" John Wiley and Sons, Chichester 2007; issue 1: 35 pages.
50. Röder E et al. "Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care" J Allergy Clin Immunol 2007; 119: 892-898.
51. Cox LS et al. "Sublingual immunotherapy: a comprehensive review" J Allergy Clin Immunol 2006; 117: 1021-1035.